International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Int J Gynecol Cancer · ISSN (e) 1525-1438 · 137 papers in corpus
other 2023
doi:10.1136/ijgc-2022-003363 ·PMID:36170996
guideline 2023
doi:10.1136/ijgc-2022-004213 ·PMID:36958755

The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) …

observational 2023
doi:10.1136/ijgc-2022-004038 ·PMID:36898699

OBJECTIVE: The aim of this study was to analyze the clinical and reproductive outcomes of patients treated with myomectomy who were histologically diagnosed with uterine smooth muscle tumor of uncertain malignant potential (STUMP). METHODS…

meta-analysis 2022
doi:10.1136/ijgc-2022-003565 ·PMID:35948366

OBJECTIVE: Obturator nerve injury can occur as a complication of gynecologic surgeries, occurring most frequently in patients with endometriosis and genitourinary malignancies. The resulting injury causes paresthesia and major weakness in a…

diagnostic-accuracy 2022
doi:10.1136/ijgc-2022-003911 ·PMID:36384753

OBJECTIVE: Ovarian cancer is known for its poor prognosis, which is mainly due to the lack of early symptoms and adequate screening options. In this study we evaluated whether mutational analysis in cervicovaginal and endometrial samples co…

observational 2022
doi:10.1136/ijgc-2022-003935 ·PMID:36368707

OBJECTIVE: We sought to describe clinicopathologic and treatment factors associated with oncologic outcomes in patients with early-stage ovarian clear cell carcinoma undergoing complete staging and in a sub-set of these patients undergoing …

observational 2022
doi:10.1136/ijgc-2022-003882 ·PMID:36368706

OBJECTIVE: To evaluate the efficacy and safety of gonadotropin-releasing hormone agonist (GnRHa) combined with a levonorgestrel-releasing intrauterine device (LNG-IUD) or aromatase inhibitor (letrozole) in women with endometrial carcinoma o…

other 2022
doi:10.1136/ijgc-2022-003544 ·PMID:35667673
observational 2022
doi:10.1136/ijgc-2022-003383 ·PMID:35641004

OBJECTIVE: To assess potential predictive variables for nodal metastasis and survival outcomes in patients with newly diagnosed, low-grade endometrial stromal sarcoma. METHODS: We performed a single-institution, retrospective analysis of c…

observational 2022
doi:10.1136/ijgc-2022-003353 ·PMID:35437272

OBJECTIVES: Cancer-related systemic inflammation has been associated with prognosis in multiple cancer types. Conversely, local inflammation, which is characterized by dense intratumoral immune infiltrates, is a favorable predictor of survi…

observational 2022
doi:10.1136/ijgc-2022-003931 ·PMID:36526289

OBJECTIVE: Current evidence has shown how laparoscopic surgery results in shorter hospital stay, faster recovery, and better aesthetic results. However, we do not have information on populations in Latin America and the impact that the soci…

case-report 2022
doi:10.1136/ijgc-2022-003430 ·PMID:35545291

BACKGROUND: Although immune checkpoint blockade has demonstrated limited effectiveness against ovarian cancer, subset analyses from completed trials suggest possible superior efficacy in the clear cell carcinoma subtype. OBJECTIVE: To desc…

other 2021
doi:10.1136/ijgc-2021-002973 ·PMID:34518240

BACKGROUND: ARID1A (AT-rich interactive domain containing protein 1A) loss-of-function mutations have been reported in gynecological cancers, including rarer subtypes such as clear cell carcinoma. Preclinical studies indicate that ARID1A mu…

review 2021
doi:10.1136/ijgc-2020-001656 ·PMID:32948640

Clear cell carcinoma of the ovary has distinct biology and clinical behavior. There are significant geographical and racial differences in the incidence of clear cell carcinoma compared with other epithelial ovarian tumors. Patients with cl…

guideline 2021
doi:10.1136/ijgc-2021-002565 ·PMID:34112736

The European Society of Gynaecological Oncology (ESGO), the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), the International Ovarian Tumour Analysis (IOTA) group, and the European Society for Gynaecological Endosc…

other 2021
doi:10.1136/ijgc-2020-001541 ·PMID:32907814

BACKGROUND: Risk-reducing salpingo-oophorectomy is the 'gold standard' for preventing tubo-ovarian cancer in women at increased risk. However, when performed in pre-menopausal women, it results in premature menopause and associated detrimen…

case-report 2021
doi:10.1136/ijgc-2021-002799 ·PMID:34417254
observational 2021
doi:10.1136/ijgc-2021-002913 ·PMID:34610972

OBJECTIVE: Plasma energy ablation vaporizes tissues similar to carbon dioxide laser ablation, but is not hindered by the unique hazards and regulation of laser technology. We aimed to evaluate the complication rate and effectiveness of plas…

rct 2020
doi:10.1136/ijgc-2020-001604 ·PMID:32591370

BACKGROUND: The optimal treatment of recurrent ovarian clear cell carcinoma remains unknown. There is increasing rationale to support the role of immune checkpoint inhibitors targeting the programmed cell death protein 1 (PD-1)/programmed d…

other 2020
doi:10.1136/ijgc-2019-001028 ·PMID:32221022

BACKGROUND: Many women diagnosed with gynecological cancers undergo adjuvant therapy, which may lead to transient or permanent menopause that ultimately leads to urogenital syndrome and vulvovaginal atrophy. Studies advise against the use o…

other 2020
doi:10.1136/ijgc-2019-001146 ·PMID:32029483
observational 2020
doi:10.1136/ijgc-2020-001612 ·PMID:32883699

INTRODUCTION: Although lobular endocervical glandular hyperplasia is a benign disorder of the uterine cervix, its potential as a precursor of minimal deviation adenocarcinoma has been reported. However, the natural history of the disease an…

other 2020
doi:10.1136/ijgc-2020-001478 ·PMID:32675055

OBJECTIVE: Radical vaginal trachelectomy is the fertility-preserving surgery for patients with early stage cervical cancer. However, it has not gained widespread approval by gynecologic oncologists because of difficulties in the dissection …

other 2020
doi:10.1136/ijgc-2020-001210 ·PMID:32354795

OBJECTIVE: Only few studies have focused on tumor markers used in the preoperative diagnosis of endometriosis-related ovarian neoplasms, and previous studies have only assessed serum CA125 levels. This study investigated the significance of…

case-report 2019
doi:10.1136/ijgc-2019-000808 ·PMID:31451559